📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

In vitro and in vivo activity of ML302F: a thioenolate inhibitor of VIM-subfamily metallo ß-lactamases (2016)

First Author: Betts J

Attributed to: Accelerate CHNUK AMR discovery: Establishing joint China/UK training and research platforms enabling highthroughput fragment based inhibitor discovery funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c5md00380f

Publication URI: http://dx.doi.org/10.1039/c5md00380f

Type: Journal Article/Review

Parent Publication: MedChemComm

Issue: 1